Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 21/10/2009
PIL Climesse 2 mg/0.7mg film coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/10/2009 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 30/04/2009 and displayed until 21/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 11/11/2008 and displayed until 30/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/09/2008 and displayed until 11/11/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 18/04/2008 and displayed until 08/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/03/2008 and displayed until 18/04/2008
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 23/01/2007 and displayed until 13/03/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 18/03/2005 and displayed until 23/01/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 03/03/2004 and displayed until 18/03/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 23/01/2002 and displayed until 03/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 21/05/2001 and displayed until 23/01/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   norethisterone
   estradiol valerate